| « Monday's Health Winners & Losers | Sudbury family hosts blood donor clinic in honour of family member ... » |
Proteolix Names Matthew Ferguson to Newly-Created Position of ...
02/26/08
Proteolix Names Matthew Ferguson to Newly-Created Position of ...
Link: http://www.sunherald.com/447/story/392184.html
SunHerald.com, MS - 17 hours ago Carfilzomib is currently in Phase II clinical studies to evaluate its safety and efficacy in multiple myeloma, lymphoma and solid tumor malignancies.
XML Feeds